These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15794717)

  • 1. The safety and tolerability of botulinum toxins for the treatment of cervical dystonia.
    Brashear A
    Expert Opin Drug Saf; 2005 Mar; 4(2):241-9. PubMed ID: 15794717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.
    Chapman MA; Barron R; Tanis DC; Gill CE; Charles PD
    Clin Ther; 2007 Jul; 29(7):1325-37. PubMed ID: 17825685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin therapy for cervical dystonia.
    Jankovic J
    Neurotox Res; 2006 Apr; 9(2-3):145-8. PubMed ID: 16785112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia.
    Han Y; Stevens AL; Dashtipour K; Hauser RA; Mari Z
    J Neurol; 2016 Apr; 263(4):772-80. PubMed ID: 26914922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of botulinum toxin type F injections to treat torticollis in patients with immunity to botulinum toxin type A.
    Greene PE; Fahn S
    Mov Disord; 1993 Oct; 8(4):479-83. PubMed ID: 8232357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The botulinum toxins in the treatment of cervical dystonia.
    Brashear A
    Semin Neurol; 2001; 21(1):85-90. PubMed ID: 11346029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction.
    Lew MF
    Clin J Pain; 2002; 18(6 Suppl):S142-6. PubMed ID: 12569961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical dystonia: from pathophysiology to pharmacotherapy.
    Patel S; Martino D
    Behav Neurol; 2013; 26(4):275-82. PubMed ID: 22713419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin in blepharospasm and oromandibular dystonia: comparing different botulinum toxin preparations.
    Bhidayasiri R; Cardoso F; Truong DD
    Eur J Neurol; 2006 Feb; 13 Suppl 1():21-9. PubMed ID: 16417594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    Costa J; Borges A; Espírito-Santo C; Ferreira J; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004314. PubMed ID: 15674940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeomin in the treatment of cervical dystonia.
    Benecke R
    Eur J Neurol; 2009 Dec; 16 Suppl 2():6-10. PubMed ID: 20002740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum Toxin Treatment of Cervical Dystonia.
    Bledsoe IO; Comella CL
    Semin Neurol; 2016 Feb; 36(1):47-53. PubMed ID: 26866496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
    Wynn RL
    Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
    [No Abstract]   [Full Text] [Related]  

  • 18. Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.
    Figgitt DP; Noble S
    Drugs; 2002; 62(4):705-22. PubMed ID: 11893235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.
    Yun JY; Kim JW; Kim HT; Chung SJ; Kim JM; Cho JW; Lee JY; Lee HN; You S; Oh E; Jeong H; Kim YE; Kim HJ; Lee WY; Jeon BS
    Mov Disord; 2015 Feb; 30(2):206-13. PubMed ID: 25476727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.